Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels |
---|---|---|---|
1 | |||
Toxic epidermal necrolysis | postmarketing | x | |
Renal failure chronic | postmarketing | x | |
Abdominal pain | x | ||
Anaemia | x | ||
Anorexia | x | ||
Asthenia | x | ||
Back pain | x | ||
Neoplasm malignant | x | ||
Constipation | x | ||
Cough | x | ||
Dehydration | x | ||
Diarrhoea | x | ||
Dyspnoea | x | ||
Oedema | x | ||
Epistaxis | x | ||
Rash | x | ||
Fatigue | x | ||
Body temperature increased | x | ||
Hypokalaemia | x | ||
Leukopenia | x | ||
Nausea | x | ||
Neutropenia | x | ||
Night sweats | x | ||
Pain in extremity | x | ||
Pancytopenia | x | ||
Pruritus | x | ||
Tachycardia | x | ||
Thrombocytopenia | x | ||
Tumour lysis syndrome | x | ||
Upper respiratory tract infection | x | ||
Vomiting | x | ||
Liver function test abnormal | x | ||
Sepsis | x | ||
Cardio-respiratory arrest | x | ||
Pharyngolaryngeal pain | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |